Archives

Loading Events

Major Depressive Disorder In Chronic Kidney Disease

Major depressive disorder (MDD) affects more than 260 million people worldwide. The reported prevalence of depression in patients with chronic kidney disease (CKD) ranges from 20-65%. This presentation provides an overview of both MDD and CKD and discusses their overlap of symptomology.

*Speakers are paid consultants of Otsuka Pharmaceutical Development & Commercialization, Inc (OPDC). Jill Green, PhD, and Chip Meyer, PhD are employees of OPDC.

In order to register for this event, you must be a NephU member. It is free and easy to join. Please click the “join” button below. Or for existing members please log-in to register for the event. If you have trouble logging-in, please contact NephU’s customer service team at info@NephU.org or call 1-855-343-2129.
Featured Speakers
Rima Kang

Rima Kang, MD

Assistant Professor of Clinical Medicine
    Division of Nephrology, The Ohio State University, Columbus, Ohio*

Upon joining faculty at Ohio State, Dr. Kang has become the lead nephrologist in cystic kidney disease care and was instrumental in developing a specialty clinic at Ohio State with an emphasis in ADPKD and CKD. Dr. Kang continues to advocate for improved patient care and is an active member in multiple associations and committees, including the National Kidney Foundation (NKF), the Internal Medicine Quality and Patient Safety Committee, and the Internal Medicine Diversity and Inclusion Committee. Dr. Kang received her medical degree from Northeast Ohio Medical University, and completed her residency in Internal Medicine at the University of Cincinnati Medical Center in Cincinnati, Ohio. Dr. Kang then went on to complete a distinguished fellowship in Nephrology at The Ohio State University Wexner Medical Center.

Jill A. Green

Jill A. Green, PhD

Nephrology Medical Science Liaison
    Otsuka Pharmaceutical Development & Commercialization, Inc.*

Jill A. Green, PhD, is a Medical Science Liaison in the nephrology division at Otsuka Pharmaceutical Development & Commercialization, Inc. Dr. Green received her PhD in biomedical sciences, with a specialization in biochemical and molecular basis of disease. She went on to hold a research scientist role at The James Comprehensive Cancer Center at The Ohio State University, specializing in oncology pre-clinical research before taking a position as a Regulatory Compliance Officer where she managed thoracic oncology clinical trials at The James Cancer Hospital.

Dr. Green has been a proud member of the PKD Foundation – Columbus, OH chapter for over 12 years where she has been active in fundraising and advocacy efforts.

Chip Meyer

Chip Meyer, PhD

Senior Medical Science Liaison
    Otsuka Pharmaceutical Development & Commercialization, Inc.*

Chip Meyer, PhD, is a Senior Medical Science Liaison in the neuroscience division at Otsuka Pharmaceutical Development & Commercialization, Inc. Dr. Meyer received hisPhD in Behavioral Neuroscience and Psychopharmacology from the University of Kentucky where he conducted pre-clinical research and drug development in the area of substance use disorders. He went on to complete a postdoctoral fellowship in Human BehavioralPharmacology at the University of Vermont where he conducted clinical research in substance use disorders.

Location

Online via NephU.org